Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

PRP injections can effectively treat alopecia areata.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Zebrafish are useful for studying and developing treatments for human skin diseases.

Using neurohormones to control keratin can lead to new skin disease treatments.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.